磁珠联合基质辅助激光解吸电离飞行时间质谱技术检测肾透明细胞癌尿液差异蛋白的初步应用

董德鑫; 纪志刚; 李汉忠; 严维刚; 张玉石

doi:10.24920/J1001-9294.2017.046

Your Location：

Home >

Browse articles >

磁珠联合基质辅助激光解吸电离飞行时间质谱技术检测肾透明细胞癌尿液差异蛋白的初步应用

中国医学科学杂志(英文版) 2017年32卷第4期页码：248-252

ORIGINAL ARTICLE | Updated：2024-04-10

- 磁珠联合基质辅助激光解吸电离飞行时间质谱技术检测肾透明细胞癌尿液差异蛋白的初步应用
- Affiliations：
  
  Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
- Author bio：
  
  * Corresponding author Tel: 86-10-69152520,E-mail: jzg1129@medmail.com.cn
- Funds：
- DOI：10.24920/J1001-9294.2017.046
  中图分类号：
- 收稿日期：2017-03-17，
  
  网络出版日期：2017-12-30，
  
  纸质出版日期：2017-12
- Accepted：
Scan QR Code
董德鑫, 纪志刚, 李汉忠, 等. 磁珠联合基质辅助激光解吸电离飞行时间质谱技术检测肾透明细胞癌尿液差异蛋白的初步应用[J]. 中国医学科学杂志(英文版), 2017,32(4):248-252.

Dong Dexin, Ji Zhigang, Li Hanzhong, et al. Preliminary Application of WCX Magnetic Bead-Based Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Analyzing the Urine of Renal Clear Cell Carcinoma[J]. Chinese medical sciences journal, 2017, 32(4): 248-252.
董德鑫, 纪志刚, 李汉忠, 等. 磁珠联合基质辅助激光解吸电离飞行时间质谱技术检测肾透明细胞癌尿液差异蛋白的初步应用[J]. 中国医学科学杂志(英文版), 2017,32(4):248-252. DOI： 10.24920/J1001-9294.2017.046.

Dong Dexin, Ji Zhigang, Li Hanzhong, et al. Preliminary Application of WCX Magnetic Bead-Based Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Analyzing the Urine of Renal Clear Cell Carcinoma[J]. Chinese medical sciences journal, 2017, 32(4): 248-252. DOI： 10.24920/J1001-9294.2017.046.

摘要

目的

弱阳离子磁珠联合基质辅助激光解吸电离飞行时间质谱( matrix-assisted laser desorption /ionization time of flight mass spectrometry

MALDI-TOF MS) 技术对肾透明细胞癌进行尿液差异蛋白研究

寻找尿液中特征性差异蛋白

评估该技术对肾透明细胞癌早期诊断的价值。

方法

收集活检证实的新发肾透明细胞癌患者11例（男10例

女1例

年龄46-78岁

平均63.0岁）

以及健康志愿者10例（均男性

年龄25-32岁

平均28.7岁）。采集病例组和对照组晨尿

应用磁珠联合MALDI-TOF MS技术检测尿液中的蛋白质谱

利用ClinProTools2.2软件通过遗传算法和支持向量机确认两组尿液中的差异蛋白

筛选对肾透明细胞癌具有诊断价值的特征蛋白。

结果

肾透明细胞癌癌患者与健康组尿液内存在差异蛋白峰160个

其中具有显著性差异的蛋白峰1个（2221.71 Da

=0.0304）。遗传算法和支持向量机优化选择发现有13个差异蛋白峰对诊断预测模型有价值。

结论

磁珠联合MALDI-TOF MS技术检测尿液差异蛋白可能在肾透明细胞癌的早期诊断方面具有一定的临床应用价值。

Abstract

Objective

To evaluate the application of weak cation exchange (WCX) magnetic bead-based Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in detecting differentially expressed proteins in the urine of renal clear cell carcinoma (RCCC) and its value in the early diagnosis of RCCC.

Methods

Eleven newly diagnosed patients (10 males and 1 female

aged 46-78

mean 63 years) of renal clear cell carcinoma by biopsy and 10 healthy volunteers (all males

aged 25-32

mean 29.7 years) were enrolled in this study. Urine samples of the RCCC patients and healthy controls were collected in the morning. Weak cation exchange (WCX) bead-based MALDI-TOF MS technique was applied in detecting differential protein peaks in the urine of RCCC. ClinProTools2.2 software was utilized to determine the characteristic proteins in the urine of RCCC patients for the predictive model of RCCC.

Results

The technique identified 160 protein peaks in the urine that were different between RCCC patients and health controls; and among them

there was one peak (molecular weight of 2221.71 Da) with statistical significance (

=0.0304). With genetic algorithms and the support vector machine

we screened out 13 characteristic protein peaks for the predictive model.

Conclusions

The application of WCX magnetic bead-based MALDI-TOF MS in detecting differentially expressed proteins in urine may have potential value for the early diagnosis of RCCC.

关键词

Keywords

references

Chow WH , Devesa SS , Warren JL , Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999 ; 281 : 1628 - 31 .doi: 10.1001/jama.281.17.1628 https://doi.org/10.1001/jama.281.17.1628 .

Aebersold R , Mann M. Mass spectrometry-based proteomics. Nature 2003 ; 422 ( 6928 ): 198 - 207 . doi: 10.1038/ nature01511 https://doi.org/10.1038/nature01511 .

Kumarathasan P , Mohottalage S , Goegan P , Vincent R. An optimized protein in-gel digest method for reliable proteome characterization by MALDI-TOF-MS analysis. Anal Biochem 2005 ; 346 : 85 - 9 . doi: 10.1016/j.ab.2005.06.004 https://doi.org/10.1016/j.ab.2005.06.004 .

Yang X , Xi C , Jin J , Zhou L , Su J , Liu L , et al. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients. Ann Diagn Pathol 2015 ; 19 : 57 - 63 . doi: 10.1016/j.anndiagpath.2015.01.006 https://doi.org/10.1016/j.anndiagpath.2015.01.006 .

Hollingsworth JM , Miller DC , Daignault S , Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006 ; 98 : 1331 - 4 . doi: 10.1093/jnci/djj362 https://doi.org/10.1093/jnci/djj362 .

Weinberger SR , Dalmasso EA , Fung ET. Current achievements using ProteinChip® Array Technology. Curr Opin Chem Biol 2002 ; 6 : 86 - 91 . doi: 10.1016/s1367-5931(01) 00282-4 https://doi.org/10.1016/s1367-5931(01)00282-4 .

Wong MY , Yu KO , Poon TC , Ang IL , Law MK , Chan KYW , et al. A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification. Electrophoresis 2010 ; 31 : 1721 - 30 . doi: 10.1002/elps.200900 571 https://doi.org/10.1002/elps.200900 571 .

Giebel R , Worden C , Rust SM , Kleinheinz GT , Robbins M , Sandrin TR. Microbial fingerprinting using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) applications and challenges. Adv Appl Microbiol 2010 ; 71 : 149 - 84 . doi: 10.1016/S0065-2164(10)71006-6 https://doi.org/10.1016/S0065-2164(10)71006-6 .

Fung ET, Wright GL Jr, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges. Curr Opin Mol Ther 2000 ; 2 : 643 - 50 .

Ghaheri A , Shoar S , Naderan M , Hoseini SS. The Applications of genetic algorithms in medicine. Oman Med J 2015 ; 30 : 406 - 16 . doi: 10.5001/omj.2015.82 https://doi.org/10.5001/omj.2015.82 .

浏览量

656

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Regional Differences of the Urinary Proteomes in Healthy Chinese Individuals

Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities